Oligodendrocyte development and myelin biogenesis: Parsing out the roles of glycosphingolipids

Physiology

Volumn 24, Issue 5, 2009, Pages 290-297

  Jackman, Nicole ^a   Ishii, Akihiro ^a   Bansal, Rashmi ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID;

ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MEMBRANE; GENETICS; GLIA; HUMAN; MYELIN SHEATH; NERVE CELL; OLIGODENDROGLIA; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DIFFERENTIATION; GLYCOSPHINGOLIPIDS; HUMANS; MEMBRANE MICRODOMAINS; MYELIN SHEATH; NEUROGLIA; NEURONS; OLIGODENDROGLIA;

EID: 70349932435     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00016.2009     Document Type: Review

References (110)

1. Bansal R. Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelina-tion and remyelination. Dev Neurosci 24: 35-46, 2002.
2. Bansal R, Pfeiffer SE. Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 anti- galactocerebroside. J Neurosci Res 32: 309-316, 1992.
3. Bansal R, Pfeiffer SE. Regulation of gene expression in mature oligodendrocytes by the specialized myelin-like membrane environment: antibody perturbation in culture with the monoclonal antibody R-mAb. Glia 12: 173-179, 1994.
4. Bansal R, Pfeiffer SE. Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci USA 86: 6181-6185, 1989.
5. Bansal R, Stefansson K, Pfeiffer SE. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 58: 2221-2229, 1992.
6. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. Multiple and novel specificities of monoclonal antibodies O1, O4, and R- mAb used in analysis of oligodendrocyte development. J Neurosci Res 24: 548-557, 1989.
7. Bansal R, Winkler S, Bheddah S. Negative regulation of oligo-dendrocyte differentiation by galactosphingolipids. J Neurosci 19: 7913-7924, 1999.
8. Baron W, Colognato H, ffrench-Constant C. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49: 467-479, 2004.
9. Baron W, Decker L, Colognato H, ffrench-Constant C. Regulation of integrin growth factor interactions in oligoden-drocytes by lipid raft microdomains. Curr Biol 13: 151-155, 2003.
10. Bhat MA. Molecular organization of axo-glial junctions. Curr Opin Neurobiol 13: 552-559, 2003.
11. Boggs JM, Gao W, Hirahara Y. Myelin glycosphingolipids, galactosylceramide and sulfatide, participate in carbohydrate-carbohydrate interactions between apposed membranes and may form glycosynapses between oligodendro-cyte and/or myelin membranes. Biochim Biophys Acta 1780: 445-455, 2008.
12. Boggs JM, Menikh A, Rangaraj G. Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers. Biophys J 78: 874-885, 2000.
13. Boggs JM, Wang H, Gao W, Arvanitis DN, Gong Y, Min W. A glycosynapse in myelin? Glycoconjugate J 21: 97-110, 2004.
14. Bosio A, Binczek E, Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebro-side synthesis. Proc Natl Acad Sci USA 93: 13280-13285, 1996.
15. Bosio A, Binczek E, Haupt W, Stoffel W. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice. J Neurochem 70: 308-315, 1998.
16. Bosio A, Büssow H, Adam J, Stoffel W. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res 292: 199-210, 1998.
17. Bremer E, Hakomori S. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function. Biochem Biophys Res Commun 106: 711-718, 1982.
18. Brown D, London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem Biophys Res Commun 240: 1-7, 1997.
19. Bryant MR, Marta CB, Kim FS, Bansal R. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligoden- drocytes. Glia 57: 935-946, 2009.
20. Cheong K, Zacchetti D, Schneeberger E, Simons K. VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. Proc Natl Acad Sci USA 96: 6241-6248, 1999.
21. Coetzee T, Dupree JL, Popko B. Demyelination and altered expression of myelin-associated gly-coprotein isoforms in the central nervous system of galactolipid-deficient mice. J Neurosci Res 54: 613-622, 1998.
22. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86: 209-219, 1996.
23. Coetzee T, Suzuki K, Popko B. New perspectives on the function of myelin galactolipids. Trends Neurosci 21: 126-130, 1998. (Pubitemid 28080675)
24. Collins BE, Yang LJ, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar RL. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem 272: 1248-1255, 1997.
25. Dupree JL, Coetzee T, Blight A, Suzuki K, Popko B. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. J Neurosci 18: 1642-1649, 1998.
26. Dupree JL, Coetzee T, Suzuki K, Popko B. Myelin abnormalities in mice deficient in galactocerebro-side and sulfatide. J Neurocytol 27: 649-659, 1998.
27. Dupree JL, Girault JA, Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J Cell Biol 147: 1145-1152, 1999.
28. Dupree JL, Popko B. Genetic dissection of myelin galactolipid function. J Neurocytol 28: 271-279, 1999.
29. Dupree JL, Suzuki K, Popko B. Galactolipids in the formation and function of the myelin sheath. Microsc Res Tech 41: 431- 440, 1998. (Pubitemid 28308906)
30. Dyer CA, Benjamins JA. Antibody to galactocere-broside alters organization of oligodendroglial membrane sheets in culture. J Neurosci 8: 4307-4318, 1988.
31. 2+ responses in oligodendrocytes. J Neurosci Res 30: 699-711, 1991.
32. Dyer CA, Benjamins JA. Glycolipids and trans-membrane signaling: antibodies to galactocere-broside cause an influx of calcium in oligodendro-cytes. J Cell Biol 111: 625-633, 1990.
33. Erne B, Sansano S, Frank M, Schaeren-Wiemers N. Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem 82: 550-562, 2002.
34. Fewou SN, Jackman N, van Meer G, Bansal R, Pfeiffer SE. Functional dynamics of myelin lipids. In: Handbook of Neurochemistry and Molecular Neurobiology (3rd ed.), edited by Lajtha A. Vol. 8, Neural Lipids, edited by Tettamanti G, Goracci G. Berlin, Germany: Springer. In press.
35. Frank M. MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond. Prog Neurobiol 60: 531-544, 2000.
36. Frank M, van der Haar ME, Schaeren-Wiemers N, Schwab ME. rMAL is a glycosphingolipid-associat-ed protein of myelin and apical membranes of epithelial cells in kidney and stomach. J Neurosci 18: 4901-4913, 1998.
37. Füllekrug J, Simons K. Lipid rafts and apical membrane traffic. Ann NY Acad Sci 1014: 164-169, 2004.
38. Gard AL, Pfeiffer SE. Two proliferative stages of the oligodendrocyte lineage (A2B5+O4- and O4+GalC-) under different mitogenic control. Neuron 5: 615-625, 1990.
39. Gielen E, Baron W, Vandeven M, Steels P, Hoekstra D, Ameloot M. Rafts in oligodendro-cytes: evidence and structure-function relationship. Glia 54: 499-512, 2006.
40. Günther J. Impulse conduction in the myelinated giant fibers of the earthworm. Structure and function of the dorsal nodes in the median giant fiber. J Comp Neurol 168: 505-531, 1976.
41. Hasse B, Bosse F, Müller HW. Proteins of peripheral myelin are associated with glycosphin-golipid/cholesterol-enriched membranes. J Neurosci Res 69: 227-232, 2002.
42. Hirahara Y, Bansal R, Honke K, Ikenaka K, Wada Y. Sulfatide is a negative regulator of oligodendro-cyte differentiation: development in sulfatide-null mice. Glia 45: 269-277, 2004.
43. Hoetzl S, Sprong H, van Meer G. The way we view cellular (glyco)sphingolipids. J Neurochem 103: 3-13, 2007.
44. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T, Yoshida N, Wada Y, Taniguchi N. Paranodal junction formation and spermatogenesis require sulfoglycol-ipids. Proc Natl Acad Sci USA 99: 4227-4232, 2002.
45. Hoshi T, Suzuki A, Hayashi S, Tohyama K, Hayashi A, Yamaguchi Y, Takeuchi K, Baba H. Nodal protrusions, increased Schmidt- Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves. Glia 55: 584- 594, 2007.
46. Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H, Baba H. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinat-ed axon but not essential for initial cluster formation. J Neurosci 22: 6507-6514, 2002.
47. Kasahara K, Sanai Y. Functional roles of glycosph-ingolipids in signal transduction via lipid rafts. Glycoconj J 17: 153-162, 2000.
48. Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, Sandhoff K, Proia RL. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276: 6885-6888, 2001.
49. Kelm S, Pelz A, Schauer R, Filbin M T, Tang S, de Bellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4: 965-972, 1994.
50. Kim T, Fiedler K, Madison DL, Krueger WH, Pfeiffer SE. Cloning and characterization of MVP17: a developmentally regulated myelin protein in oligodendrocytes. J Neurosci Res 42: 413-422, 1995.
51. Kim T, Pfeiffer SE. Myelin glycosphingolipid/cho-lesterol-enriched microdomains selectively sequester the non-compact myelin proteins CNP and MOG. J Neurocytol 28: 281-293, 1999.
52. Kim T, Pfeiffer SE. Subcellular localization and detergent solubility of MVP17/rMAL, a lipid-raft associated protein in oligodendrocytes and myelin. J Neurosci Res 69: 217-226, 2002.
53. Krämer EM, Klein C, Koch T, Boytinck M, Trotter J. Compartmentation of Fyn kinase with glycosylphos-phatidylinositol-anchored molecules in oligoden-drocytes facilitates kinase activation during myelina-tion. J Biol Chem 274: 29042-29049, 1999.
54. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J. Myelination in the absence of myelin- associated glycoprotein. Nature 369: 747-750, 1994.
55. Maier O, Baron W, Hoekstra D. Reduced raft-association of NF155 in active MS-lesions is accompanied by the disruption of the paranodal junction. Glia 55: 885-895, 2007.
56. Maier O, van der Heide T, van Dam AM, Baron W, de Vries H, Hoekstra D. Alteration of the extracellular matrix interferes with raft association of neu-rofascin in oligodendrocytes. Potential significance for multiple sclerosis? Mol Cell Neurosci 28: 390-401, 2005.
57. Marta CB, Montano MB, Taylor CM, Taylor AL, Bansal R, Pfeiffer SE. Signaling cascades activated upon antibody cross-linking of myelin oligoden-drocyte glycoprotein: potential implications for multiple sclerosis. J Biol Chem 280: 8985-8993, 2005.
58. Marta CB, Taylor CM, Cheng S, Quarles RH, Bansal R, Pfeiffer SE. Myelin associated glycopro-tein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol 1: 35-46, 2004.
59. Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci 23: 5461-5471, 2003.
60. Martín-Belmonte F, Puertollano R, Millán J, Alonso MA. The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and fischer rat thyroid cell lines. Mol Biol Cell 11: 2033-2045, 2000.
61. Marcus J, Dupree JL, Popko B. Effects of galac-tolipid elimination on oligodendrocyte development and myelination. Glia 30: 319-328, 2000.
62. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53: 372-381, 2006.
63. Marcus J, Popko B. Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim Biophys Acta 1573: 406-413, 2002.
64. Miljan EA, Bremer EG. Regulation of growth factor receptors by gangliosides. Sci STKE 160: 1-10, 2002.
65. Mohan PS, Laitinen J, Merenmies J, Rauvala H, Jungalwala FB. Sulfoglycolipids bind to adhesive protein amphoterin (P30) in the nervous system. Biochem Biophys Res Commun 182: 689-696, 1992.
66. Montag D, Giese K P, Bartsch U, Martini R, Lang Y, Blüthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave KA, Zielasek J, Toyka K V, Lipp H P, Schachner M. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13: 229-246, 1994. (Pubitemid 24238427)
67. Nave KA, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535-561, 2008.
68. Norton WT, Cammer W. Isolation and characterization of myelin. In: Myelin, edited by Morell P. New York: Plenum, 1984, p. 147-195.
69. Okamura N, Stoskopf M, Hendricks F, Kishimoto Y. Phylogenetic dichotomy of nerve glycosphin-golipids. Proc Natl Acad Sci USA 82: 6779-6782, 1985.
70. Okamura N, Stoskopf M, Yamaguchi H, Kishimoto Y. Lipid composition of the nervous system of earthworms (Lumbricus terrestris). J Neurochem 45: 1875-1879, 1985.
71. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. Myelin-associated gly-coprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195: 208-217, 2005.
72. Pedraza L, Huang JK, Colman DR. Organizing principles of the axoglial apparatus. Neuron 30: 335-344, 2001.
73. Peles E, Salzer JL. Molecular domains of myelinat-ed axons. Curr Opin Neurobiol 10: 558-565, 2000.
74. Pesheva P, Gloor S, Schachner M, Probstmeier R. Tenascin-R is an intrinsic autocrine factor for oligo-dendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J Neurosci 17: 4642-4651, 1997.
75. Pfeiffer SE, Warrington AE, Bansal R. The oligo-dendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197, 1993.
76. Pike LJ. Rafts defined: a report on the Keystone symposium on lipid rafts and cell function. J Lipid Res 47: 1597-1598, 2006.
77. Poliak S, Gollan L, Salomon D, Berglund EO, Ohara R, Ranscht B, Peles E. Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. J Neurosci 21: 7568-7575, 2001.
78. Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 4: 968-980, 2003.
79. Popko B. Myelin galactolipids: mediators of axon-glial interactions? Glia 29: 149-153, 2000.
80. Ranscht B, Clapshaw PA, Price J, Noble M, Seifert W. Development of oligodendrocytes and schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 79: 2709-2713, 1982.
81. Rasband MN, Taylor CM, Bansal R. Paranodal transverse bands are required for maintenance but not initiation of Nav1.6 sodium channel clustering in CNS optic nerve axons. Glia 44: 173-182, 2003.
82. Roberts DD, Rao CN, Magnani JL, Spitalnik SL, Liotta LA, Ginsburg V. Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci USA 82: 1306-1310, 1985.
83. Rosenbluth J. Multiple functions of the paranodal junction of myelinated nerve fibers. J Neurosci Res. In press.
84. Rosenbluth J, Dupree JL, Popko B. Nodal sodium channel domain integrity depends on the conformation of the paranodal junction, not on the presence of transverse bands. Glia 41: 318-325, 2003.
85. Rosenbluth J, Liang WL, Liu Z, Guo D, Schiff R. Expanded CNS myelin sheaths formed in situ in the presence of an IgM antigalactocerebroside-pro- ducing hybridoma. Neurosci 16: 2635-2641, 1996.
86. Rosenbluth J, Moon D. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebro-side monoclonal antibodies. J Neurosci Res 71: 104-109, 2003.
87. Rusnati M, Tanghetti E, Urbinati C, Tulipano G, Marchesini S, Ziche M, Presta M. Interaction of fibroblast growth factor-2 (FGF-2) with free gan-gliosides: biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell 10: 313-327, 1999.
88. Salzer JL. Polarized domains of myelinated axons. Neuron 40: 297-318, 2003.
89. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U. The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol 166: 731-742, 2004.
90. Schafer D P, Bansal R, Hedstrom KL, Pfeiffer SE, Rasband MN. Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci 24: 3176-3185, 2004.
91. Schafer D P, Rasband MN. Glial regulation of the axonal membrane at nodes of Ranvier. Curr Opin Neurobiol 16: 508-514, 2006.
92. Schnaar RL, Collins BE, Wright L P, Kiso M, Tropak MB, Roder JC, Crocker PR. Myelin-associated gly-coprotein binding to gangliosides. Structural specificity and functional implications. Ann NY Acad Sci 845: 92-105, 1998.
93. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96: 7532-7537, 1999.
94. Sherman DL, Brophy PJ. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6: 683-690, 2005.
95. Shroff SM, Pomicter AD, Chow WN, Fox MA, Colello RJ, Henderson SC, Dupree JL. Adult CST-null mice maintain an increased number of oligo-dendrocytes. J Neurosci Res. In press.
96. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997.
97. Simons K, Toomre D. Lipid rafts and signal trans-duction. Nat Rev Mol Cell Biol 1: 31-39, 2000.
98. Simons M, Krämer EM, Thiele C, Stoffel W, Trotter J. Assembly of myelin by association of prote-olipid protein with cholesterol- and galactosylce-ramide-rich membrane domains. J Cell Biol 151: 143-154, 2000.
99. Sommer I, Schachner M. Cells that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes. Neurosci Lett 29: 183-188, 1982.
100. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, Furukawa K, Furukawa K, Rasband MN, Yuki N. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55: 746-757, 2007.
101. Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, Okada M, Fukumoto S, Haraguchi M, Takeda N, Fujimura K, Sakae M, Kishikawa M, Shiku H, Furukawa K, Aizawa S. Mice with disrupted GM2/GD2 synthase gene lack complex gan-gliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA 93: 10662-10667, 1996.
102. Taylor C, Marta CB, Bansal R, Pfeiffer SE. The transport, assembly, and function of myelin lipids. In: Myelin Biology and Disorders, edited by Lazzarini R, Griffin J, Lassman H, Nave K-A, Miller R, Trapp B. New York: Elsevier, 2004, p. 57-88.
103. Trapp BD, Andrews SB, Cootauco C, Quarles R. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 109: 2417-2426, 1989.
104. Trapp BD, Kidd GJ. Structure of the myelinated axon. In: Myelin Biology and Disorders, edited by Lassarini R. New York: Elsevier, 2004, p. 3-27.
105. Van Brocklyn J, Bremer EG, Yates AJ. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells. J Neurochem 61: 371-374, 1993.
106. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. Gangliosides are functional nerve cell ligands for mylin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 99: 8412-8417, 2002.
107. Vyas AA, Schnaar RL. Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration. Biochemie 83: 677-682, 2001.
108. Yamashita T, Wu Y P, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA 102: 2725-2730, 2005.
109. Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL. Gangliosides are neu-ronal ligands for myelin- associated glycoprotein. Proc Natl Acad Sci USA 93: 814-818, 1996.
110. Yim SH, Farrer RG, Hammer JA, Yavin E, Quarles RH. Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside. J Neurosci Res 38: 268-281, 1994.